Education

• B.S. (Pharmacy), University of Rhode Island, 1982
• M.B.A.,  University of Rhode Island, 1984
• M.S. (Pharmacy Administration), University of Rhode Island, 1988
• Ph.D. (Epidemiology), Brown University, 1992

Research Interests:

• Drug benefit design issues, formulary compliance strategies, pharmacoeconomic evaluation, decision analysis, outcomes assessment and drug utilization management.

Selected Publications:

• Larrat EP, Stutte G, Wheeler RM. Effect of biogenic compound production on human health in closed life support systems. National Aeronautics and Space Administration (Technical Report). Washington, DC, 2005. [under review]
   

• Abugosh SM, Kogut SJ, Andrade SE, Larrat EP, Gurwitz JH. Persistence with lipid-lowering therapy; Influence of the type of lipid-lowering agent and drug benefit plan option in elderly patients. Journal of Managed Care Pharmacy 2004; 10(5): 404-411.
   
• Kogut SJ, Andrade SE, Larrat EP, Willey C. The influence of nonadherence on changes in oral antidiabetic drug therapy. Pharmacoepidemiology and Drug Safety. 2004; 13:591-598.
   
• Dhall J, Larrat EP, Lapane KL.  Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 2002, 22(1):88-96.
   
• Kogut S, Perfetto E, Larrat EP. United States regulation of health care economic data. In Vogenberg FR, editor. Introduction to applied pharmacoeconomics. New York: McGraw-Hill, 2000.
   

• Bayliss, M.S., Larrat, E.P., Buchner, D. and Ware, J.E.  ITG-Asthma Short Form: Manual and Interpretation Guide. Lincoln, R.I.: QualityMetric Inc. :2000 .

© University
of Rhode Island
Disclaimer

The University is an affirmative action/equal opportunity employer.
All rights reserved